Atara Biotherapeutics Stock In The News
| ATRA Stock | USD 0.71 0.01 0.74% |
The tone or emotional content of news articles related to Atara Biotherapeutics can affect its prices. Positive news sentiment can lead to an increase in demand for Atara Biotherapeutics' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Atara Biotherapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Atara Biotherapeutics. The specific impact of Atara Biotherapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Atara Biotherapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Atara Biotherapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Atara Biotherapeutics Backtesting and Atara Biotherapeutics Hype Analysis. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.
Atara |
Atara Biotherapeutics Today Top News and Investor Outlook
Atara Biotherapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Atara and other traded companies coverage. We help investors stay connected with Atara headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on Atara Stock performance. Please note that trading solely based on the Atara Biotherapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.Atara Biotherapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Atara earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Atara Biotherapeutics that are available to investors today. That information is available publicly through Atara media outlets and privately through word of mouth or via Atara internal channels. However, regardless of the origin, that massive amount of Atara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Atara Biotherapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Atara Biotherapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Atara Biotherapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Atara Biotherapeutics alpha.
Atara Largest EPS Surprises
Earnings surprises can significantly impact Atara Biotherapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-03-28 | 2023-12-31 | -0.48 | -0.56 | -0.08 | 16 | ||
2022-05-05 | 2022-03-31 | -0.98 | -0.87 | 0.11 | 11 | ||
2016-11-04 | 2016-09-30 | -0.77 | -0.88 | -0.11 | 14 | ||
2018-05-08 | 2018-03-31 | -0.92 | -1.05 | -0.13 | 14 | ||
2015-11-05 | 2015-09-30 | -0.56 | -0.43 | 0.13 | 23 | ||
2017-05-04 | 2017-03-31 | -0.74 | -0.88 | -0.14 | 18 |
Atara Biotherapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Atara Biotherapeutics Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
18th of April 2024
Atara Biotherapeutics Shares Cross Below 50 Day Moving Average of 0.73 - Defense World at news.google.com
5th of April 2024
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635 at finance.yahoo.com
28th of March 2024
Atara Biotherapeutics Q4 Earnings Snapshot at finance.yahoo.com
21st of March 2024
Citigroup Inc. Has 671000 Stock Position in Atara Biotherapeutics, Inc. - Defense World at news.google.com
15th of March 2024
Disposition of 3879 shares by Jill Henrich of Atara Biotherapeutics at 0.72 subject to Rul... at MacroaxisInsider
7th of March 2024
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Ful... at finance.yahoo.com
29th of February 2024
Atara Biotherapeutics Gets FDA Clearance for ATA3219 IND Application at marketwatch.com
1st of February 2024
Atara stock spikes on peer-reviewed data for lead asset at seekingalpha.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atara Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atara Biotherapeutics' short interest history, or implied volatility extrapolated from Atara Biotherapeutics options trading.
Check out Atara Biotherapeutics Backtesting and Atara Biotherapeutics Hype Analysis. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Atara Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherapeutics. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atara Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.61) | Revenue Per Share 0.081 | Quarterly Revenue Growth 13.457 | Return On Assets (0.62) | Return On Equity (20.15) |
The market value of Atara Biotherapeutics is measured differently than its book value, which is the value of Atara that is recorded on the company's balance sheet. Investors also form their own opinion of Atara Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Atara Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atara Biotherapeutics' market value can be influenced by many factors that don't directly affect Atara Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atara Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atara Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atara Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.